
Ipamorelin + CJC-1295 (No DAC) Blend (5mg/5mg) co-packages two synthetic peptides that act on complementary receptors of the GH-secretory axis: Ipamorelin, a selective GHS-R1a (ghrelin receptor) agonist, and CJC-1295 No DAC (Mod GRF 1-29), a stabilized 29-residue GHRH analog. Ipamorelin engages the ghrelin receptor while CJC-1295 No DAC engages the GHRH receptor; the two pathways converge on somatotroph cAMP and calcium signaling, making the pair a standard model for studying additive and synergistic secretagogue effects in laboratory systems. Each peptide is supplied as lyophilized powder, 5 mg, >=98% HPLC purity.